Quest Diagnostics Incorporated (DGX) Stock Analysis

Quest Diagnostics Incorporated (DGX) Stock Analysis — AI Research | MarketCI

DGX

Market Closed

Quest Diagnostics Incorporated

NYSEHealthcare Medical - Diagnostics & Research

55.00K employees

CEO: James E. Davis

Founded: 1996

$195.00

+$0.00(+NaN%)

Market Cap

21.59B

Beta

0.59

52W Range

N/A

Dividend Yield

1.67%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

DGX Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for DGX built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Buy

Pass %

71.43%

Score

5/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$226.20

AI Price Target

Machine learning • Price prediction

$192.30

Market Sentiment

News & social media analysis

0.05

Value Investor Price

Classic value analysis

$58.75

Financial Health

Bankruptcy risk assessment

3.27

Quality Score

Financial strength rating

7.00

AI Investment Grade

Deep analysis of filings & news

78.00

Key Investment Highlights

Important factors affecting DGX investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

59.52% Good

Conditions Met

25.00/42.00

Due Diligence Score

59.52%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Fail
	Fail
	Fail
	Fail
	Pass

Showing 1 to 6 of 46 conditions